Targeting the Notch signaling pathway: molecular mechanisms and therapeutic strategies for cardiac repair after myocardial infarction
Frontiers in Cardiovascular Medicine · 21.11.2025 · 12
DOI: 10.3389/fcvm.2025.1669362 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 21.11.2025. Verfasst von ZhiCheng Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The People's Hospital of Yuhuan, Yuhuan, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myocardial infarction (MI) is a leading cause of death globally and is characterized by extensive cardiomyocyte death, fibrosis, and diminished cardiac function, leading to heart failure. The limited regenerative capacity and excessive fibrosis of the heart highlight the need for effective therapeutic strategies. The Notch signaling pathway, known for its role in cell fate determination and tissue repair, is transiently activated after MI in cardiomyocytes, endothelial cells, and smooth muscle cells. This activation modulates cardiac repair by reducing oxidative stress and apoptosis, regulating inflammation, promoting angiogenesis, and inhibiting fibrosis. Recent research has focused on targeting the Notch pathway to increase myocardial regeneration and angiogenesis via the use of gene therapy, small-molecule regulators, and cell-based therapies. For example, delivering Notch ligands through hydrogels has yielded promising results in preclinical studies, enhancing cardiac function and promoting angiogenesis. This review examines the molecular mechanisms by which Notch signaling influences cardiac repair post-MI. We also discuss its specific roles in cardiomyocyte regeneration, fibrosis inhibition, and angiogenesis enhancement. Additionally, this study evaluated the therapeutic potential of Notch pathway modulation, addressing clinical translation challenges, safety concerns, and the importance of personalized treatment strategies. Future research directions include leveraging gene editing and nanotechnology-based drug delivery to improve the efficacy and safety of Notch-targeted therapies for cardiovascular diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The People's Hospital of Yuhuan, Yuhuan, China.
- Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- General Practice Department, Shanghai Tongji Hospital, Shanghai, China.
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Zitieren
APA
Zhang, Z., Xie, F., Cheng, J., Liu, X., Wang, X., Long, J., Feng, Q., & Yuan, D. (2025). Targeting the Notch signaling pathway: molecular mechanisms and therapeutic strategies for cardiac repair after myocardial infarction. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1669362
Vancouver
Zhang Z, Xie F, Cheng J, Liu X, Wang X, Long J, et al. Targeting the Notch signaling pathway: molecular mechanisms and therapeutic strategies for cardiac repair after myocardial infarction. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1669362
BibTeX
@article{Zhang2025,
author = {Zhang, ZhiCheng and Xie, FengQun and Cheng, Jie and Liu, Xinyue and Wang, Xinran and Long, Jun and Feng, QiMao and Yuan, Dongping},
title = {Targeting the Notch signaling pathway: molecular mechanisms and therapeutic strategies for cardiac repair after myocardial infarction},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1669362}
}
EUVIMED